Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Effects of ganciclovir treatment in a murine model of cytomegalovirus-induced hearing loss.

Haller TJ, Price MS, Lindsay SR, Hillas E, Seipp M, Firpo MA, Park AH.

Laryngoscope. 2019 Jun 11. doi: 10.1002/lary.28134. [Epub ahead of print]

PMID:
31184781
2.

County-level Variation in Use of Surgery and Cancer-specific Survival for Stage I-II Pancreatic Adenocarcinoma.

Swords DS, Mulvihill SJ, Brooke BS, Stoddard GJ, Firpo MA, Scaife CL.

Ann Surg. 2019 Apr 8. doi: 10.1097/SLA.0000000000003236. [Epub ahead of print]

PMID:
30973391
3.

Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity.

Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Alvarez H, Bernard V, Ferri-Borgogno S, Brand R, Adler DG, Firpo MA, Mulvihill SJ, Molldrem JJ, Feng Z, Taguchi A, Maitra A, Hanash SM.

Nat Commun. 2019 Jan 16;10(1):254. doi: 10.1038/s41467-018-08109-6.

4.

Conscious Sedation for Pediatric Peritonsillar Abscess: Comparison of Anesthetic Approaches.

Graham ME, Neal AK, Newberry IC, Firpo MA, Park AH.

Otolaryngol Head Neck Surg. 2019 Apr;160(4):706-711. doi: 10.1177/0194599818821905. Epub 2019 Jan 1.

PMID:
30598050
5.

Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.

Swords DS, Mulvihill SJ, Brooke BS, Skarda DE, Firpo MA, Scaife CL.

Surgery. 2019 Apr;165(4):751-759. doi: 10.1016/j.surg.2018.10.035. Epub 2018 Dec 11.

PMID:
30551868
6.

Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative Chemotherapy.

Swords DS, Francis SR, Lloyd S, Garrido-Laguna I, Mulvihill SJ, Gruhl JD, Christensen MC, Stoddard GJ, Firpo MA, Scaife CL.

J Gastrointest Surg. 2019 Jul;23(7):1401-1413. doi: 10.1007/s11605-018-3953-0. Epub 2018 Sep 5.

PMID:
30187332
7.

Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?

Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KS.

Surgery. 2018 Dec;164(6):1178-1184. doi: 10.1016/j.surg.2018.07.014. Epub 2018 Aug 28.

PMID:
30170819
8.

Causes of Death and Conditional Survival Estimates of Medium- and Long-term Survivors of Pancreatic Adenocarcinoma.

Swords DS, Mulvihill SJ, Firpo MA, Scaife CL.

JAMA Oncol. 2018 Aug 1;4(8):1129-1130. doi: 10.1001/jamaoncol.2018.2442. No abstract available.

9.

Pancreatic cancer as a sentinel for hereditary cancer predisposition.

Young EL, Thompson BA, Neklason DW, Firpo MA, Werner T, Bell R, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-Albright LA, Tavtigian SV.

BMC Cancer. 2018 Jun 27;18(1):697. doi: 10.1186/s12885-018-4573-5.

10.

Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery.

Swords DS, Zhang C, Presson AP, Firpo MA, Mulvihill SJ, Scaife CL.

Surgery. 2018 Apr;163(4):753-760. doi: 10.1016/j.surg.2017.10.054. Epub 2017 Dec 13.

PMID:
29248179
11.

Role of BAG3 in cancer progression: A therapeutic opportunity.

De Marco M, Basile A, Iorio V, Festa M, Falco A, Ranieri B, Pascale M, Sala G, Remondelli P, Capunzo M, Firpo MA, Pezzilli R, Marzullo L, Cavallo P, De Laurenzi V, Turco MC, Rosati A.

Semin Cell Dev Biol. 2018 Jun;78:85-92. doi: 10.1016/j.semcdb.2017.08.049. Epub 2017 Aug 31. Review.

PMID:
28864347
12.

Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice.

Almishaal AA, Mathur PD, Hillas E, Chen L, Zhang A, Yang J, Wang Y, Yokoyama WM, Firpo MA, Park AH.

PLoS Pathog. 2017 Aug 31;13(8):e1006599. doi: 10.1371/journal.ppat.1006599. eCollection 2017 Aug.

13.

Hospital-level Variation in Utilization of Surgery for Clinical Stage I-II Pancreatic Adenocarcinoma.

Swords DS, Mulvihill SJ, Skarda DE, Finlayson SRG, Stoddard GJ, Ott MJ, Firpo MA, Scaife CL.

Ann Surg. 2019 Jan;269(1):133-142. doi: 10.1097/SLA.0000000000002404.

PMID:
28700442
14.

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.

Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Firpo MA, Mulvihill SJ, Katz MH, Brennan P, Feng Z, Taguchi A, Hanash SM.

J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw266.

15.

Implications of inaccurate clinical nodal staging in pancreatic adenocarcinoma.

Swords DS, Firpo MA, Johnson KM, Boucher KM, Scaife CL, Mulvihill SJ.

Surgery. 2017 Jul;162(1):104-111. doi: 10.1016/j.surg.2016.12.029. Epub 2017 Feb 21.

16.

Biomarkers in pancreatic adenocarcinoma: current perspectives.

Swords DS, Firpo MA, Scaife CL, Mulvihill SJ.

Onco Targets Ther. 2016 Dec 9;9:7459-7467. doi: 10.2147/OTT.S100510. eCollection 2016. Review.

17.

Violet 405-nm light: a novel therapeutic agent against common pathogenic bacteria.

Barneck MD, Rhodes NLR, de la Presa M, Allen JP, Poursaid AE, Nourian MM, Firpo MA, Langell JT.

J Surg Res. 2016 Dec;206(2):316-324. doi: 10.1016/j.jss.2016.08.006. Epub 2016 Aug 9.

PMID:
27884325
18.

Violet 405 nm light: A novel therapeutic agent against β-lactam-resistant Escherichia coli.

Rhodes NL, de la Presa M, Barneck MD, Poursaid A, Firpo MA, Langell JT.

Lasers Surg Med. 2016 Mar;48(3):311-7. doi: 10.1002/lsm.22457. Epub 2015 Dec 29.

PMID:
26711625
19.

BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages.

Rosati A, Basile A, D'Auria R, d'Avenia M, De Marco M, Falco A, Festa M, Guerriero L, Iorio V, Parente R, Pascale M, Marzullo L, Franco R, Arra C, Barbieri A, Rea D, Menichini G, Hahne M, Bijlsma M, Barcaroli D, Sala G, di Mola FF, di Sebastiano P, Todoric J, Antonucci L, Corvest V, Jawhari A, Firpo MA, Tuveson DA, Capunzo M, Karin M, De Laurenzi V, Turco MC.

Nat Commun. 2015 Nov 2;6:8695. doi: 10.1038/ncomms9695.

20.

Early detection of sporadic pancreatic cancer: summative review.

Chari ST, Kelly K, Hollingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto M, Cleeter DF, Firpo MA, Gambhir SS, Go VL, Hines OJ, Kenner BJ, Klimstra DS, Lerch MM, Levy MJ, Maitra A, Mulvihill SJ, Petersen GM, Rhim AD, Simeone DM, Srivastava S, Tanaka M, Vinik AI, Wong D.

Pancreas. 2015 Jul;44(5):693-712. doi: 10.1097/MPA.0000000000000368. Review.

21.

Defective apical extrusion signaling contributes to aggressive tumor hallmarks.

Gu Y, Shea J, Slattum G, Firpo MA, Alexander M, Mulvihill SJ, Golubovskaya VM, Rosenblatt J.

Elife. 2015 Jan 26;4:e04069. doi: 10.7554/eLife.04069.

22.

Screening for pancreatic cancer.

Poruk KE, Firpo MA, Mulvihill SJ.

Adv Surg. 2014;48:115-36. Review.

PMID:
25293611
23.

HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.

Wang AS, Lodi A, Rivera LB, Izquierdo-Garcia JL, Firpo MA, Mulvihill SJ, Tempero MA, Bergers G, Ronen SM.

NMR Biomed. 2014 Nov;27(11):1361-70. doi: 10.1002/nbm.3198. Epub 2014 Sep 9.

24.

Prospects for developing an accurate diagnostic biomarker panel for low prevalence cancers.

Firpo MA, Boucher KM, Mulvihill SJ.

Theor Biol Med Model. 2014 Aug 5;11:34. doi: 10.1186/1742-4682-11-34.

25.

The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma.

von Figura G, Fukuda A, Roy N, Liku ME, Morris Iv JP, Kim GE, Russ HA, Firpo MA, Mulvihill SJ, Dawson DW, Ferrer J, Mueller WF, Busch A, Hertel KJ, Hebrok M.

Nat Cell Biol. 2014 Mar;16(3):255-67. doi: 10.1038/ncb2916. Epub 2014 Feb 23.

26.

Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.

Kendrick ZW, Firpo MA, Repko RC, Scaife CL, Adler DG, Boucher KM, Mulvihill SJ.

HPB (Oxford). 2014 Jul;16(7):670-6. doi: 10.1111/hpb.12199. Epub 2013 Dec 6.

27.

A comparison of different murine models for cytomegalovirus-induced sensorineural hearing loss.

Wang Y, Patel R, Ren C, Taggart MG, Firpo MA, Schleiss MR, Park AH.

Laryngoscope. 2013 Nov;123(11):2801-6. doi: 10.1002/lary.24090. Epub 2013 Apr 24.

PMID:
23616191
28.

Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.

Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, Mulvihill SJ.

Pancreas. 2013 Mar;42(2):193-7. doi: 10.1097/MPA.0b013e31825e354d.

29.

The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.

Poruk KE, Gay DZ, Brown K, Mulvihill JD, Boucher KM, Scaife CL, Firpo MA, Mulvihill SJ.

Curr Mol Med. 2013 Mar;13(3):340-51. Review.

30.

Comparative analysis of detection methods for congenital cytomegalovirus infection in a Guinea pig model.

Park AH, Mann D, Error ME, Miller M, Firpo MA, Wang Y, Alder SC, Schleiss MR.

JAMA Otolaryngol Head Neck Surg. 2013 Jan;139(1):82-6. doi: 10.1001/jamaoto.2013.1090.

PMID:
23329096
31.

Toward development of a surface-enhanced Raman scattering (SERS)-based cancer diagnostic immunoassay panel.

Granger JH, Granger MC, Firpo MA, Mulvihill SJ, Porter MD.

Analyst. 2013 Jan 21;138(2):410-6. doi: 10.1039/c2an36128k.

32.

Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training.

Gounder SS, Kannan S, Devadoss D, Miller CJ, Whitehead KJ, Odelberg SJ, Firpo MA, Paine R 3rd, Hoidal JR, Abel ED, Rajasekaran NS.

PLoS One. 2012;7(9):e45697. doi: 10.1371/journal.pone.0045697. Epub 2012 Sep 24. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/8690bb36-3c5d-48a6-b3be-39a2b50896e1. Whitehead, Kevin S [corrected to Whitehead, Kevin J]. PLoS One. 2013;8(6). doi: 10.1371/annotation/684807c2-1777-4008-9eda-c6036553b082.

33.

Screening for pancreatic cancer: why, how, and who?

Poruk KE, Firpo MA, Adler DG, Mulvihill SJ.

Ann Surg. 2013 Jan;257(1):17-26. doi: 10.1097/SLA.0b013e31825ffbfb. Review.

34.

Seamless, axially aligned, fiber tubes, meshes, microbundles and gradient biomaterial constructs.

Jose RR, Elia R, Firpo MA, Kaplan DL, Peattie RA.

J Mater Sci Mater Med. 2012 Nov;23(11):2679-95. doi: 10.1007/s10856-012-4739-7. Epub 2012 Aug 14.

35.

Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle.

Miller CJ, Gounder SS, Kannan S, Goutam K, Muthusamy VR, Firpo MA, Symons JD, Paine R 3rd, Hoidal JR, Rajasekaran NS.

Biochim Biophys Acta. 2012 Jun;1822(6):1038-50. doi: 10.1016/j.bbadis.2012.02.007. Epub 2012 Feb 15.

36.

Correlating matrix metalloproteinase-9 sinus secretion levels with tissue biopsy levels.

Wilson MA, Orlandi RR, Firpo MA.

Int Forum Allergy Rhinol. 2011 Mar-Apr;1(2):106-8. doi: 10.1002/alr.20043.

PMID:
22287327
37.

β-catenin is selectively required for the expansion and regeneration of mature pancreatic acinar cells in mice.

Keefe MD, Wang H, De La O JP, Khan A, Firpo MA, Murtaugh LC.

Dis Model Mech. 2012 Jul;5(4):503-14. doi: 10.1242/dmm.007799. Epub 2012 Jan 19.

38.

Silk-hyaluronan-based composite hydrogels: a novel, securable vehicle for drug delivery.

Elia R, Newhide DR, Pedevillano PD, Reiss GR, Firpo MA, Hsu EW, Kaplan DL, Prestwich GD, Peattie RA.

J Biomater Appl. 2013 Feb;27(6):749-62. doi: 10.1177/0885328211424516. Epub 2011 Nov 15.

PMID:
22090427
39.

Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

Fukuda A, Wang SC, Morris JP 4th, Folias AE, Liou A, Kim GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ, Hebrok M.

Cancer Cell. 2011 Apr 12;19(4):441-55. doi: 10.1016/j.ccr.2011.03.002.

40.

Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice.

Rajasekaran NS, Varadharaj S, Khanderao GD, Davidson CJ, Kannan S, Firpo MA, Zweier JL, Benjamin IJ.

Antioxid Redox Signal. 2011 Mar 15;14(6):957-71. doi: 10.1089/ars.2010.3587. Epub 2011 Feb 2.

41.

Inverse association between adiposity and telomere length: The Fels Longitudinal Study.

Lee M, Martin H, Firpo MA, Demerath EW.

Am J Hum Biol. 2011 Jan-Feb;23(1):100-6. doi: 10.1002/ajhb.21109.

42.

Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.

Poruk KE, Firpo MA, Huerter LM, Scaife CL, Emerson LL, Boucher KM, Jones KA, Mulvihill SJ.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2605-10. doi: 10.1158/1055-9965.EPI-10-0178. Epub 2010 Aug 20.

43.

Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma.

Scaife CL, Shea J, Emerson L, Boucher K, Firpo MA, Beckerle MC, Mulvihill SJ.

HPB (Oxford). 2010 Jun;12(5):352-8. doi: 10.1111/j.1477-2574.2010.00177.x.

44.

Phenotype and genotype of pancreatic cancer cell lines.

Deer EL, González-Hernández J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ.

Pancreas. 2010 May;39(4):425-35. doi: 10.1097/MPA.0b013e3181c15963. Review. Erratum in: Pancreas. 2018 Jul;47(6):e37.

45.

Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels.

Elia R, Fuegy PW, VanDelden A, Firpo MA, Prestwich GD, Peattie RA.

Biomaterials. 2010 Jun;31(17):4630-8. doi: 10.1016/j.biomaterials.2010.02.043. Epub 2010 Mar 15.

46.

Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.

Firpo MA, Gay DZ, Granger SR, Scaife CL, DiSario JA, Boucher KM, Mulvihill SJ.

World J Surg. 2009 Apr;33(4):716-22. doi: 10.1007/s00268-008-9853-9.

47.

Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels.

Peattie RA, Pike DB, Yu B, Cai S, Shu XZ, Prestwich GD, Firpo MA, Fisher RJ.

Drug Deliv. 2008 Aug;15(6):389-97. doi: 10.1080/10717540802035442 .

PMID:
18686083
48.

Global expression profiling identifies a novel biosignature for protein aggregation R120GCryAB cardiomyopathy in mice.

Rajasekaran NS, Firpo MA, Milash BA, Weiss RB, Benjamin IJ.

Physiol Genomics. 2008 Oct 8;35(2):165-72. doi: 10.1152/physiolgenomics.00297.2007. Epub 2008 Jul 15.

49.

Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels.

Hosack LW, Firpo MA, Scott JA, Prestwich GD, Peattie RA.

Biomaterials. 2008 May;29(15):2336-47. doi: 10.1016/j.biomaterials.2008.01.033. Epub 2008 Mar 3.

50.

Natural history of pancreatic cancer recurrence following "curative" resection in athymic mice.

Torgenson MJ, Shea JE, Firpo MA, Dai Q, Mulvihill SJ, Scaife CL.

J Surg Res. 2008 Sep;149(1):57-61. doi: 10.1016/j.jss.2007.08.024. Epub 2007 Sep 18.

PMID:
18222475

Supplemental Content

Loading ...
Support Center